Topical Janus kinase-signal transducers and activators of transcription inhibitor tofacitinib is effective in reducing nonatopic dermatitis chronic itch: A case series

J Am Acad Dermatol. 2022 Aug;87(2):400-403. doi: 10.1016/j.jaad.2022.03.012. Epub 2022 Mar 9.

Authors

Teresa Ju¹, Angelina Labib¹, Ashley Vander Does¹, Gil Yosipovitch²

Affiliations

¹ Dr Phillip Frost Department of Dermatology and Cutaneous Surgery and Miami Itch Center, University of Miami Miller School of Medicine, Miami, Florida.
² Dr Phillip Frost Department of Dermatology and Cutaneous Surgery and Miami Itch Center, University of Miami Miller School of Medicine, Miami, Florida. Electronic address: yosipog@gmail.com.

PMID: 35278487
DOI: 10.1016/j.jaad.2022.03.012

No abstract available

MeSH terms

Dermatitis*
Humans
Janus Kinases*
Piperidines / pharmacology
Piperidines / therapeutic use
Pruritus / drug therapy
Pruritus / etiology
Pyrimidines / pharmacology
Pyrimidines / therapeutic use
Pyrroles / therapeutic use

Substances

Piperidines
Pyrimidines
Pyrroles
tofacitinib
Janus Kinases